INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/04/2026
Voltar para busca
Dado oficial do USPTO
VIFOR PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5, 41, 42, 44
Data de depósito
06/02/2017
Data de registro
26/06/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/01/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
25
Localização do titular
CH
Examinador
CARROLL, DORITT
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "VIFOR PHARMA" accompanied by a design of three concentric incomplete triangles.
Titulares e representantes
Titulares
Vifor (International) AG (Vifor (International) Ltd.) (Vifor (International) Inc.)
Representantes
Marie Anne Mastrovito Womble Bond Dickinson (US) LLP
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Bleaching preparations for laundry use; cleaningpolishingabrasive preparations; degreasing preparations for household use; skin soaps; perfumeryessential oilscosmeticshair lotions; dentifrices
Classe 5
Pharmaceutical or veterinary preparations for use in oncology and diabetes; pharmaceutical or veterinary preparations for the treatment or prevention of cardiovascularcirculatoryrenal systemkidneycardio-renalimmune systemgastroenterologicalgastrointestinalstomachdermatologicalhematologicalbonerespiratorygeneticallergicinflammationinfectiouspaincentral nervous systemendocrinologyhormonalmuscularrheumaticocular and metabolic diseases and disorders; pharmaceutical and veterinary preparations used as immune system stimulator; pharmaceutical preparations for the treatment or prevention of mineral deficiencies or mineral overload; pharmaceutical preparations for the treatment or prevention of metal deficiencies or metal overload; pharmaceutical preparations for the treatment or prevention of vitamin deficiencies or vitamin overloadvitamin and mineral supplementsvitamin preparations and mineral preparations for medical use; sanitary preparations for medical purposes; dietetic foods adapted for medical or veterinary use; food for babies; food supplements for humans and animals; medical plastersmedical dressings; material for dental fillings and dental impressions; disinfectants
Classe 41
Education servicesnamely organization of seminars and workshops in the field of pharmaceutical preparations; training services in the field of pharmaceutical preparationsnamely medical and pharmaceutical training in the use and dispensing of pharmaceutical preparations and distributing printed course materials in conjunction therewith; providing on-line journalsblogs in the medicalpharmaceutical and health fields
Classe 42
Research and development of new productspharmaceutical preparationsfor others; design and development of computers and software; scientific and technological services for othersnamely testing and developing of pharmaceutical preparations
Classe 44
Medical services; veterinary services; hygienic and beauty care
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
14/02/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
14/02/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/09/2025
C71T
CANCELLED SECTION 71
10/01/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
24/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
24/10/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
24/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
24/10/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/11/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/11/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
28/09/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
28/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/09/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
26/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2018
PUBO
PUBLISHED FOR OPPOSITION
10/04/2018
GPNX
NOTIFICATION PROCESSED BY IB
06/04/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/03/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
06/03/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/03/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
06/03/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/03/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/11/2017
GNFR
FINAL REFUSAL E-MAILED
21/11/2017
CNFR
FINAL REFUSAL WRITTEN
21/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/10/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/10/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/10/2017
RFNT
REFUSAL PROCESSED BY IB
20/05/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/05/2017
RFRR
REFUSAL PROCESSED BY MPU
04/05/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2017
CNRT
NON-FINAL ACTION WRITTEN
01/05/2017
DOCK
ASSIGNED TO EXAMINER
01/05/2017
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/03/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VIFOR PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.